DoW Neurofibromatosis Exploration-Hypothesis Development Award
Defense Health Agency Contracting Activity - DHACA
Posted Jun 25, 2026
Description
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Distinctive Features:
• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.
• Preliminary Data: Preliminary and/or published data is encouraged but not required.
AI Summary
The Neurofibromatosis Research Program's Exploration-Hypothesis Development Award funds innovative research projects that explore high-risk, high-gain concepts in neurofibromatosis (NF) research, aiming to establish a foundation for future studies. Researchers with a well-formulated, testable hypothesis based on strong scientific rationale are eligible to apply.
Funding Details
Key Dates
Quick Facts
- CFDA Number
- 12.420
- Funder Type
- Federal Agency
- Grant Level
- FEDERAL
- Last Verified
- Jun 26, 2026
Geographic Scope
national
GL-1C0F271c0f2765-b9f9-45d9-83ef-a0a2db990e7a
Intelligence
Ready to apply?
Visit the funder's website to start your application.